The current status of trademark application 3818561 for NUCLEXIS is IR Cancelled.
The trademark information displayed on this page is public information and is provided for informational purposes only. This information may be incomplete, inaccurate, or outdated, and IndiaFilings does not guarantee its accuracy. IndiaFilings is an independent platform and is not associated, affiliated, or connected with any trademark listed in this database. We do not represent or speak on behalf of any such trademark. If you are trying to contact a specific trademark, please use their official channels. IndiaFilings cannot assist with queries directed at other companies.
| Application Number | 3818561 |
| Trademark Status | IR Cancelled |
| Trademark Class | 5 |
| Application Date | 2018-01-16 |
| Proprietor Name | Karyopharm Therapeutics Inc. |
| Appropriate Office | IR DIVISION |
| State | STATE NOT SPECIFIED |
| Trademark Type | DEVICE |
| User Details | Proposed to be used |
| Goods And Services Details | [CLASS : 5] Pharmaceutical preparations, namely, drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation in humans and animals. |
Similar trademarks found for this brand
| Brand | Class | Status |
|---|---|---|
| NUCLEXIS | 5 | IR Cancelled |
Common questions about NUCLEXIS.